Confluent Buys Minnesota Nitinol Maker Northern Nitinol
The acquisition adds a Minnesota-based Nitinol manufacturer with over 50 years of device design expertise to Confluent Medical Technologies' portfolio.
Updated on Nov. 6, 2026 in Healthcare
Confluent Medical Technologies, a medical device and materials science contract manufacturer, announced its acquisition of Northern Nitinol, a Minnesota-based Nitinol manufacturer. Northern Nitinol's facility joins Confluent's portfolio, integrating its engineering and rapid prototyping capabilities.
Why it matters
The deal strengthens Confluent's strategy to offer what it describes as the most comprehensive and reliable Nitinol supply chain in the industry. It also expands Confluent's footprint in Minnesota's Medical Alley, a hub for medical device development.
Northern Nitinol has more than 50 years of expertise in device design, rapid prototyping, and product development, and its founder spent 11 years building the company. The announcement did not disclose the acquisition price or post-deal headcount.
The players
Confluent Medical Technologies
Confluent Medical Technologies is a medical device and materials science contract manufacturer specializing in Nitinol and polymer components, with facilities across the United States and abroad.
Dean Schauer
Dean Schauer serves as Chairman, President, and CEO of Confluent Medical Technologies, leading the company's manufacturing and acquisition strategy.
Northern Nitinol
Northern Nitinol is a Minnesota-based Nitinol manufacturer located in the state's Medical Alley, known for device design and rapid prototyping.
Mike Davis
Mike Davis is the founder and president of Northern Nitinol, who spent 11 years building the company.
The details
Confluent acquired Northern Nitinol and folded its engineering and rapid prototyping capabilities into Confluent's portfolio, with the Minnesota facility added to its operations. Confluent also operates a Nitinol Center of Excellence in Fremont, California, and has facilities across several U.S. states as well as in Costa Rica and Hyderabad, India.
Timeline
Nov. 6, 2026: Confluent announced the acquisition of Northern Nitinol.
Market Landscape
Nitinol is a nickel-titanium shape-memory alloy widely used in medical devices, and consolidation among specialized contract manufacturers is concentrating capacity in a few hands. Confluent's deal adds Minnesota-based Nitinol production to its California Center of Excellence, expanding its position in that niche supply market.
Hospitals and device makers that source Nitinol components may see changes in supplier relationships as Confluent integrates Northern Nitinol. Customers should watch for any announced shifts in pricing, lead times, or product availability from the combined operations.
The takeaway
Consolidation among specialized Nitinol suppliers can shift where and how medical device components are made, so buyers in the healthcare supply chain should track how Confluent structures its combined operations.
Further reading
Explore more Minnesota Healthcare coverage for context on the state's medical device sector.
Source note: This article includes information reported by The Manila times.
